Porkert S, Mai P, Jonak C, Weihsengruber F, Rappersberger K, Bauer W, et al. Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma. Acta Derm Venereol [Internet]. 2021 Feb. 2 [cited 2024 Nov. 21];101(2):adv00383. Available from: https://medicaljournalssweden.se/actadv/article/view/1030